Combinations Of Substituted 2,3-dihydroimidazo[1,2-c]Quinazolines


The full document isn't yet available to us from the patent office.


The present invention relates to the use of 2,3-dihydroimidazo[1,2-c]quinazoline compounds, and of pharmaceutical compositions containing such compounds, for the treatment or prophylaxis of multiple myeloma, as a sole agent or in combination with other one or more other active ingredients.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Mar 31, 2010
  • Application: Sep 24, 2008
    EP EP 08164986 A
  • Priority: Sep 24, 2008
    EP EP 08164986 A

Download Citation

Sign in to the Lens